“Being in the biotechnology industry, compliance and accuracy are incredibly important for the success of our company as a whole. With TEKLYNX CENTRAL we were able to accomplish all of our labeling goals.”
TEKLYNX International, the world’s leading barcode and RFID labeling software developer and solutions provider, today reported that the implementation of browser-based, enterprise label management system, TEKLYNX CENTRAL, improved labeling accuracy and compliance by 100%, resulting in greater efficiency for global biotechnology company, bioMérieux.
Headquartered in France, bioMérieux is a multinational biotechnology company driven to improve public health around the world. With over 15,000 products, access to labels by over 400 employees, and more than 300 product, shipping, and inventory labels, bioMérieux, along with partner Eticoncept sought out TEKLYNX to offer a standardized solution for their entire labeling environment. “Our current labeling solution didn’t allow us to be centralized within our environment, that was a necessity when finding a new solution for bioMérieux,” states Jérôme Foltz, who serves as IS Manufacturing and MDM Domain Manager at bioMérieux.
Implementing TEKLYNX CENTRAL allowed the bioMérieux team to have peace of mind knowing that their labels were accurate and compliant 100% of the time. “TEKLYNX CENTRAL has improved labeling efficiency and accuracy for our entire labeling process. It is a solution that allows for seamless labeling operations as well as providing the support we need along the way,” states Foltz.
By standardizing and centralizing their labeling process, bioMérieux has gained the ability to:
With their newly implemented TEKLYNX CENTRAL solution, bioMérieux is equipped to meet their current labeling needs and are prepared for growth in the future. “We take great pride in knowing that our enterprise-level, integrated label management system improves the accuracy and compliance of labels for bioMérieux, positioning them to keep driving growth within the medical device industry around the world now and into the future,” states TEKLYNX President, Thierry Mauger.
To read more about bioMérieux' experience with TEKLYNX CENTRAL, download the full case study.
© Copyright 2023 TEKLYNX CORPORATION SAS. All Rights Reserved.